Supplier profile
Astellas Pharma s.r.o.
Every public-sector award we hold for this supplier, across Czechia, from 18 Jul 2012 to 29 Oct 2019.
Awards won
32
all time
Attributed value
€22.2m + CZK 358.2m
12 shared, unvalued
Buyers
12
public bodies
Active
2012–2019
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Fakultní nemocnice Brno | 7 | CZK 43.8m |
| Fakultní nemocnice Hradec Králové | 5 | €148k |
| Institut klinické a experimentální medicíny | 5 | €21.4m |
| Fakultní nemocnice Ostrava | 3 | €179k |
| Fakultní nemocnice v Motole | 3 | €493k + CZK 39.9m |
| Fakultní nemocnice Plzeň | 2 | not attributable |
| Fakultní nemocnice u sv. Anny v Brně | 2 | not attributable |
| Fakultní nemocnice Olomouc | 1 | not attributable |
| Institut klinické a experimentální mediciny | 1 | CZK 224.0m |
| Krajská zdravotní, a.s. | 1 | CZK 17.8m |
What they win
Awards
Showing 1–25 of 32 awards we hold
- Czechia-Brno: Antimycotics for systemic use ↗Fakultní nemocnice Brno£1.8mawarded 29 Oct 2019
- Czechia-Brno: Antimycotics for systemic use ↗Fakultní nemocnice Brno£1.3mawarded 30 Jul 2019
- Czechia-Brno: Antimycotics for systemic use ↗Fakultní nemocnice Brno£1.5mawarded 19 Apr 2019
- Czech Republic-Ústí nad Labem: Antineoplastic agents ↗Krajská zdravotní, a.s.£17.8mawarded 31 Jan 2019
- Czech Republic-Brno: Antimycotics for systemic use ↗Fakultní nemocnice Brno£1.8mawarded 22 Jan 2019
- Czech Republic-Plzeň: Various medicinal products ↗Fakultní nemocnice Plzeňshared awardawarded 17 Nov 2018
- Czech Republic-Brno: Antimycotics for systemic use ↗Fakultní nemocnice Brno£1.6mawarded 25 Oct 2018
- Czech Republic-Plzeň: Antivirals for systemic use ↗Fakultní nemocnice Plzeňshared awardawarded 3 Aug 2018
- Czech Republic-Brno: Antimycotics for systemic use ↗Fakultní nemocnice Brno£2.7mawarded 24 Jul 2018
- Czech Republic-Ostrava: Pharmaceutical products ↗Fakultní nemocnice Ostravashared awardawarded 20 Jul 2018
- Czech Republic-Brno: Antineoplastic and immunomodulating agents ↗Fakultní nemocnice u sv. Anny v Brněshared awardawarded 19 Jul 2018
- Czech Republic-Brno: Pharmaceutical products ↗Masarykův onkologický ústav£24.5mawarded 21 Jun 2018
- Czech Republic-Hradec Králové: Antibacterials for systemic use ↗Fakultní nemocnice Hradec Královéshared awardawarded 5 Apr 2018
- Czech Republic-Hradec Králové: Immunosuppressive agents ↗Fakultní nemocnice Hradec Královéshared awardawarded 4 Apr 2018
- Czech Republic-Olomouc: Immunosuppressive agents ↗Fakultní nemocnice Olomoucshared awardawarded 21 Mar 2018
- Czech Republic-Brno: Medicinal products for the blood and blood-forming organs ↗Fakultní nemocnice u sv. Anny v Brněshared awardawarded 3 Mar 2018
- Czech Republic-České Budějovice: Pharmaceutical products ↗Sdružení jihočeských nemocnic£8.2mawarded 14 Feb 2018
- Czech Republic-Ostrava: Pharmaceutical products ↗Fakultní nemocnice Ostravashared awardawarded 17 Jan 2018
- Czech Republic-Prague: General anti-infectives for systemic use and vaccines ↗Fakultní nemocnice v Motoleshared awardawarded 7 Dec 2017
- Czech Republic-Prague: Immunosuppressive agents ↗Institut klinické a experimentální mediciny£224.0mawarded 2 Dec 2017
- Czech Republic-Hradec Králové: Endocrine therapy medicinal products ↗Fakultní nemocnice Hradec Královéshared awardawarded 1 Dec 2017
- Czech Republic-Brno: Antimycotics for systemic use ↗Fakultní nemocnice Brno£33.2mawarded 25 Nov 2017
- Czech Republic-Prague: General anti-infectives for systemic use and vaccines ↗Fakultní nemocnice v Motole£39.9mawarded 8 Aug 2017
- Czech Republic-Hradec Králové: Medicinal products for the genitourinary system and hormones ↗Fakultní nemocnice Hradec Královéshared awardawarded 22 Apr 2017
- IKEM – Dodávky humánních léčivých přípravků – Echinokandiny část č. 3 Candcidas 50 mg ↗Institut klinické a experimentální medicíny€740kawarded 22 Nov 2016
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
- ASTELLAS PHARMA, S.A.258 awards
- Astellas Pharma172 awards
- ASTELLAS PHARMA S.P.A.96 awards
- Astellas Pharma A/S26 awards
- Astellas Pharma GmbH22 awards
- Astellas Pharma AB20 awards
- Astellas Pharma SAS4 awards
- Astellas Pharma (Alloga)3 awards
- Astellas Pharma (Depolabo)3 awards
- Astellas Pharma (Alloga Marseille)1 award
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.